SPYRAL HTN-ON MED study shows significant, consistent, long-term blood pressure lowering effect at two years
October 30, 2024- Medtronic plc announced new, long-term data from its SPYRAL HTN-ON MED clinical trial that showed subjects who underwent radiofrequency renal denervation with…